You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PET/CT very early response (48 hrs)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma Trial in Los Angeles (Computed Tomography, Fludeoxyglucose F-18, Positron Emission Tomography)

Recruiting
  • Glioblastoma
  • Computed Tomography
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Feb 2, 2022

Recurrent DLBCL, Refractory DLBCL Trial in Houston (Chemotherapy, Computed Tomography, Fludeoxyglucose F-18)

Completed
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Oct 27, 2022

FDG-PET/CT Imaging as Early Predictor of DP

Completed
  • Lymphoma
  • There is no intervention
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Mar 7, 2022

Advanced Hodgkin Lymphoma Trial in Worldwide (Brentuximab Vedotin, Adriamycin, Vinblastine)

Active, not recruiting
  • Advanced Hodgkin Lymphoma
  • Brentuximab Vedotin
  • +6 more
  • Antwerp, Belgium
  • +18 more
May 4, 2022

Hodgkin Lymphoma Trial in Copenhagen (ABVD + FDG-PET/CT Scan treatment adaptation, BEACOPPesc)

Withdrawn
  • Hodgkin Lymphoma
  • ABVD + FDG-PET/CT Scan treatment adaptation
  • BEACOPPesc
  • Copenhagen, Denmark
    Rigshospitalet
Feb 11, 2021

Clinical Stage III Nodal or Intransit Disease or Resectable Stage IV Melanoma Trial in Philadelphia (FDG PET/CT imaging)

Terminated
  • Clinical Stage III Nodal or Intransit Disease or Resectable Stage IV Melanoma
  • FDG PET/CT imaging
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jul 19, 2021

Early FDG PET/CT Imaging asMeasure of Response in Non-Hodgkin

Terminated
  • Non-Hodgkin Lymphoma
  • 2-Deoxy-2-[18F]fluoro-D-glucose (FDG)
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jun 1, 2021

Breast Cancer Trial in United States (Positron emission tomography (PET), Trastuzumab, Pertuzumab)

Active, not recruiting
Has Results
  • Breast Cancer
  • Positron emission tomography (PET)
  • +2 more
  • Birmingham, Alabama
  • +9 more
Jan 20, 2023

NSCLC, Stage IV Trial in Amsterdam, Leiden (18F-FDG PET-CT)

Completed
  • NSCLC, Stage IV
  • 18F-FDG PET-CT
  • Amsterdam, Netherlands
  • +1 more
Jan 25, 2021

Non Small Cell Lung Cancer, Circulating Tumor Cell, Circulating Tumor DNA Trial in Copenhagen (PET/CT)

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • PET/CT
  • Copenhagen, Denmark
  • +1 more
Oct 6, 2020

PET Perfusion Imaging Techniques and Comparing Them to CT

Active, not recruiting
  • Acute Ischemic Stroke
    • Edmonton, Alberta, Canada
      University of Alberta
    Apr 6, 2022

    Optimization of Anti-EGFR Therapy in Metastatic Colorectal

    Completed
    • Colorectal Cancer
    • (Early) Imaging of response with [18F-]-FDG PET-CT and kinase activity profiles
    • Amsterdam, Noord Holland, Netherlands
      VU University Medical Center
    Nov 3, 2020

    Metastatic Breast Cancer Trial (18F-fluorothymidine)

    Completed
    • Metastatic Breast Cancer
    • 18F-fluorothymidine
    • (no location specified)
    Jun 1, 2020

    Usefulness of PET-CT for Invasive Fungal Infection

    Not yet recruiting
    • Invasive Fungal Infections
    • PET-CT
    • Majadahonda, Madriid, Spain
    • +13 more
    Jan 15, 2023

    Renal Tumor Trial

    Not yet recruiting
    • Renal Tumor
      • (no location specified)
      Aug 2, 2023

      Role of 18F-FDG PET/CT in Gastric Cancer

      Not yet recruiting
      • Gastric Cancer
      • pet -ct
      • (no location specified)
      Jan 8, 2023

      Breast Cancer, Clinically Assessed Negative Axillary Lymph Nodes, Sentinel Lymph Node Trial in Nanjing (Omit SLNB)

      Recruiting
      • Breast Cancer
      • +2 more
      • Omit SLNB
      • Nanjing, Jiangsu, China
        the First Affiliated Hospital of Nanjing Medical University
      Jul 4, 2023

      Different Sonographic Modalities and PET-CT in Pediatric

      Not yet recruiting
      • Pediatric Lymphoma
      • ultrasonography
      • (no location specified)
      Apr 22, 2022

      Myositis, Idiopathic Inflammatory Myopathies Trial in Xiamen (68Ga-FAPI)

      Recruiting
      • Myositis
      • Idiopathic Inflammatory Myopathies
      • Xiamen, Fujian, China
        The first affiliated hospital of Xiamen University
      Jul 12, 2023

      Classical Hodgkin Lymphoma Trial in Guangzhou (Zimberelimab 240mg)

      Recruiting
      • Classical Hodgkin Lymphoma
      • Zimberelimab 240mg
      • Guangzhou, Guangdong, China
        Department of Medical Oncology, Sun Yat-Sen University Cancer Ce
      Jun 15, 2023

      Colorectal Cancer Trial in Alkmaar, Amsterdam (FAPI PET/CT)

      Recruiting
      • Colorectal Cancer
      • FAPI PET/CT
      • Alkmaar, Noord Holland, Netherlands
      • +1 more
      Aug 16, 2022

      Prostate Cancer Trial in Utrecht (PSMA-PET/CT response evaluation)

      Not yet recruiting
      • Prostate Cancer
      • PSMA-PET/CT response evaluation
      • Utrecht, Netherlands
        Roderick van den Bergh
      Sep 10, 2022

      Prostate Cancer Trial (HRS-9815 injection)

      Not yet recruiting
      • Prostate Cancer
      • HRS-9815 injection
      • (no location specified)
      Sep 25, 2023

      PET-CT Imaging in Relapsed/Refractory Acute Leukemias

      Not yet recruiting
      • B Cell
      • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Aug 4, 2023

        Myofascial Pain Trial (18F-FDG, 11C-butanol)

        Not yet recruiting
        • Myofascial Pain
        • (no location specified)
        May 22, 2023